Patents Assigned to WUHAN KANGFUDE BIOTECHNOLOGY CO., LTD.
  • Patent number: 11613745
    Abstract: The present invention relates to a recombinant OxDC expressed in a filamentous fungal host cell, methods for constructing a recombinant filamentous fungal host cell, methods for producing recombinant OxDC and the application thereof. The recombinant filamentous fungal host cell comprises one or more copies of OxDC expression cassette integrated in its genome; the expression cassette comprises a promoter, a signal peptide coding sequence, an OxDC coding sequence and a transcription terminator. The host cell can be constructed by random integration or site-specific integration. In addition, the present invention also optimizes the medium formulation for different recombinant filamentous fungal host cells. In the production of the recombinant OxDC, the final yield and enzyme activity were greatly improved. The invention effectively solves the problem that the production of OxDC in the prior art cannot be industrialized on a large scale.
    Type: Grant
    Filed: September 21, 2018
    Date of Patent: March 28, 2023
    Assignee: WUHAN KANGFUDE BIOTECHNOLOGY CO., LTD.
    Inventors: Wei Wang, Xiaofeng Wang, Yanhong Liu, He Huang, Huoqing Chen, Xianqiao Chen
  • Patent number: 11085033
    Abstract: The present invention discloses a glycosylated oxalate decarboxylase. The oxalate decarboxylase is derived from edible basidiomycetes, the glycosylated oxalate decarboxylase has an enzyme activity at the pH value of 1.5-7.5, the activity at the pH value of 1.5-2.0 is 10% greater than the optimum activity, and a specific activity is more than 2 U/mg. The present invention also discloses preparation and application of the glycosylated oxalate decarboxylase. The glycosylated oxalate decarboxylase disclosed by the present invention can keep the activity under a low pH value, and can effectively prevent and treat kidney stones.
    Type: Grant
    Filed: July 7, 2017
    Date of Patent: August 10, 2021
    Assignee: WUHAN KANGFUDE BIOTECHNOLOGY CO., LTD.
    Inventors: Haifeng Liu, Baoping Song, Xianqiao Chen, Huoqing Chen, Pei Tong, Wei Wang, Xiaofeng Wang
  • Publication number: 20210002625
    Abstract: The present invention relates to a recombinant OxDC expressed in a filamentous fungal host cell, methods for constructing a recombinant filamentous fungal host cell, methods for producing recombinant OxDC and the application thereof. The recombinant filamentous fungal host cell comprises one or more copies of OxDC expression cassette integrated in its genome; the expression cassette comprises a promoter, a signal peptide coding sequence, an OxDC coding sequence and a transcription terminator. The host cell can be constructed by random integration or site-specific integration. In addition, the present invention also optimizes the medium formulation for different recombinant filamentous fungal host cells. In the production of the recombinant OxDC, the final yield and enzyme activity were greatly improved. The invention effectively solves the problem that the production of OxDC in the prior art cannot be industrialized on a large scale.
    Type: Application
    Filed: September 21, 2018
    Publication date: January 7, 2021
    Applicant: Wuhan Kangfude Biotechnology Co., Ltd.
    Inventors: Wei WANG, Xiaofeng WANG, Yanhong LIU, He HUANG, Huoqing CHEN, Xianqiao CHEN
  • Publication number: 20200080070
    Abstract: The present invention discloses a glycosylated oxalate decarboxylase. The oxalate decarboxylase is derived from edible basidiomycetes, the glycosylated oxalate decarboxylase has an enzyme activity at the pH value of 1.5-7.5, the activity at the pH value of 1.5-2.0 is 10% greater than the optimum activity, and a specific activity is more than 2 U/mg. The present invention also discloses preparation and application of the glycosylated oxalate decarboxylase. The glycosylated oxalate decarboxylase disclosed by the present invention can keep the activity under a low pH value, and can effectively prevent and treat kidney stones.
    Type: Application
    Filed: July 7, 2017
    Publication date: March 12, 2020
    Applicant: WUHAN KANGFUDE BIOTECHNOLOGY CO., LTD.
    Inventors: Haifeng LIU, Baoping SONG, Xianqiao CHEN, Huoqing CHEN, Pei TONG, Wei WANG, Xiaofeng WANG